Hypothesis
Intravascular radiotherapy: restenosis and more?
| The first 150 words of the full text of this article appear below. |
At the end of the 1970s balloon angioplasty emerged as a new hope in the treatment of coronary atherosclerosis.1 A decade later, the implantation of endovascular stents2 did not only reduce the number of acute complications of percutaneous coronary interventions, but also the incidence of restenosis.3 Now, as we begin the new millennium, intravascular radiotherapy promises to lower the restenosis rate further and has been shown to be especially effective in treatment of in-stent restenosis.4
Restenosis develops as a response to injury, mediated by a complex
interaction of an inflammatory process, thrombus formation, proliferation and migration of smooth muscle cells (SMCs), expression of growth factors, matrix synthesis, and finally vascular
remodelling.5 The antiproliferative effects of ionising
radiation, which are widely used in treating various benign and
malignant proliferative diseases, are based on the interaction of
primary (
radiation) or secondary (
radiation) electrons with
biochemical bonds in cellular DNA,6 and
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
